Recruiting OBSERVATIONAL NCT03897374

Strategic Targeting for Optimal Prevention of Cancer (STOP-Cancer)

Sponsor: ClinLogic LLC

Updated 12 times since 2019 Last updated: Jan 24, 2025 Started: Mar 26, 2022 Primary completion: Dec 1, 2026 Completion: Dec 1, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03897374, this observational or N/A phase trial focuses on Early Detection of Cancer and remains actively recruiting participants. Sponsored by ClinLogic LLC, it has been updated 12 times since 2022, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

12 versions recorded

Feb 2025 — Present [monthly]

Recruiting
Sep 2024 — Feb 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jan 2024 — Jul 2024 [monthly]

Recruiting
Nov 2023 — Jan 2024 [monthly]

Recruiting

▶ Show 7 earlier versions

Sep 2021 — Nov 2023 [monthly]

Recruiting
Jan 2021 — Sep 2021 [monthly]

Recruiting
Apr 2020 — Jan 2021 [monthly]

Recruiting
Oct 2019 — Apr 2020 [monthly]

Recruiting
Sep 2019 — Oct 2019 [monthly]

Recruiting
Jul 2019 — Sep 2019 [monthly]

Recruiting
May 2019 — Jul 2019 [monthly]

Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ClinLogic LLC
MDGlobal

Data source: ClinLogic LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Prosper, United States